Clinical trial
Ceramide Cream in Treating Women With Cutaneous Breast Cancer
NCT00008320 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00008320 |
|---|---|
| Title | Ceramide Cream in Treating Women With Cutaneous Breast Cancer |
| Official title | A Phase II Study Of Topical Ceramide Lipids As Treatment For Cutaneous Breast Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | ceramide |
| Enrollment | 26 |
| Start date | Jan 1, 2001 |
| Primary completion | Apr 1, 2002 |
| Completion | Oct 1, 2009 |
| First posted | Mar 25, 2004 |
| Last update posted | Dec 6, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: